RAHWAY, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that new clinical and real-world data for the company’s 9-valent Human ...
OXFORD, United Kingdom, April 17, 2023 (GLOBE NEWSWIRE) -- Vaccitech plc (VACC), a clinical-stage biopharmaceutical company focused on the development of novel T cell immunotherapeutics designed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results